Clover Health Investments, Corp. CLOV
We take great care to ensure that the data presented and summarized in this overview for CLOVER HEALTH INVESTMENTS, CORP. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CLOV
View all-
Vanguard Group Inc Valley Forge, PA19.6MShares$66.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny11.1MShares$37.6 Million0.05% of portfolio
-
Black Rock Inc. New York, NY9.54MShares$32.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.88MShares$16.6 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X04.71MShares$16 Million0.02% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA4.47MShares$15.2 Million0.01% of portfolio
-
Marshall Wace, LLP London, X03.77MShares$12.8 Million0.02% of portfolio
-
State Street Corp Boston, MA2.8MShares$9.51 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.75MShares$9.35 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA2.74MShares$9.31 Million0.0% of portfolio
Latest Institutional Activity in CLOV
Top Purchases
Top Sells
About CLOV
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Insider Transactions at CLOV
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
Apr 29
2025
|
Peter J. Kuipers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
825,989
-12.06%
|
$2,477,967
$3.45 P/Share
|
Apr 18
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
38,261
-1.58%
|
$114,783
$3.6 P/Share
|
Apr 03
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
6,366
-0.19%
|
$19,098
$3.51 P/Share
|
Apr 01
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308,950
-2.74%
|
$926,850
$3.59 P/Share
|
Mar 15
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,589
-0.35%
|
$13,767
$3.66 P/Share
|
Mar 15
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
6,354
-0.19%
|
$19,062
$3.66 P/Share
|
Mar 14
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
80,524
-2.41%
|
$241,572
$3.66 P/Share
|
Mar 14
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
9,188
-0.28%
|
$27,564
$3.66 P/Share
|
Mar 07
2025
|
Carladenise Armbrister Edwards Director |
SELL
Open market or private sale
|
Direct |
200,000
-42.26%
|
$600,000
$3.61 P/Share
|
Mar 06
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Open market or private sale
|
Direct |
75,000
-3.01%
|
$225,000
$3.68 P/Share
|
Mar 06
2025
|
Karen Soares General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
52,500
-3.88%
|
$157,500
$3.8 P/Share
|
Feb 14
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,345
-0.39%
|
$21,380
$4.46 P/Share
|
Feb 08
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,535
-0.75%
|
$342,140
$4.32 P/Share
|
Jan 31
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
24,470
-0.73%
|
$97,880
$4.39 P/Share
|
Jan 31
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
18,987
-0.76%
|
$75,948
$4.39 P/Share
|
Jan 31
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
21,578
-0.65%
|
$86,312
$4.39 P/Share
|
Jan 31
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
28,553
-2.06%
|
$114,212
$4.39 P/Share
|
Jan 18
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
38,560
-1.51%
|
$154,240
$4.08 P/Share
|
Jan 07
2025
|
Vivek Garipalli Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,670,965
-54.25%
|
$5,012,895
$3.6 P/Share
|
Jan 07
2025
|
Vivek Garipalli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,670,965
+35.17%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 6.54M shares |
---|---|
Exercise of conversion of derivative security | 1.67M shares |
Open market or private purchase | 1.44M shares |
Payment of exercise price or tax liability | 5.76M shares |
---|---|
Open market or private sale | 328K shares |
Sale (or disposition) back to the issuer | 124K shares |